Stock Market News

Eli Lilly strikes $1.3 billion deal to buy gene-editing biotech Verve Therapeutics, companies say

Jun 17, 2025 - 12:14
 0
Eli Lilly strikes $1.3 billion deal to buy gene-editing biotech Verve Therapeutics, companies say
Read More

Tags:

Previous Article

TSX futures slip amid heightened Middle East tensions

Next Article

Paris Air Show 2025 Day 1: Here are the key takeaways

Related Posts

GSA and Salesforce partnership lowers Slack costs for federal agencies

GSA and Salesforce partnership lowers Slack costs for f...

May 19, 2025  0

IBM aims for quantum computer in 2029, lays out road map for larger systems

IBM aims for quantum computer in 2029, lays out road ma...

Jun 10, 2025  0

Colombia stocks lower at close of trade; COLCAP down 0.72%

May 27, 2025  0